Kaskela Law Firm Announces Investigation of Humana Inc. (HUM) and Encourages Long-Term HUM Shareholders to Contact the Firm
Investor litigation firm Kaskela Law announces that it is investigating Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company’s long-term investors.
Click here for additional information: https://kaskelalaw.com/case/humana/
Recently a federal securities fraud complaint was filed against Humana on behalf of certain investors who purchased shares of the company's stock between July 27, 2022 and October 1, 2024 (the “Wrongdoing Period”). According to the complaint, during the Wrongdoing Period, Humana and certain of its senior executive officers issued a series of materially false and misleading statements to investors about the company’s core Medicare Advantage business.
As further detailed in the complaint, the truth regarding Humana’s increased utilization began to emerge in June 2023, causing a series of stock price declines in the latter half of 2023 and during fiscal 2024.
